Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 601 AL 615

Dysfunctional microglia and tau pathology in Alzheimer's disease

Ayyubova G.

Rev Neurosci. 2022 Oct 28;34(4):443-458. doi: 10.1515/revneuro-2022-0087. Print 2023 Jun 27.

Aducanumab for the treatment of Alzheimer's disease

Tagliapietra M.

Drugs Today (Barc). 2022 Oct;58(10):465-477. doi: 10.1358/dot.2022.58.10.3422314.

The Lymphatic System in Neurological Disease and Alzheimer's Disease. A Brief Editorial

Pappolla MA, Carare RO, Poeggeler B, Wisniewski T, Sambamurti K.

Curr Alzheimer Res. 2022;19(10):689-693. doi: 10.2174/1567205020666221028111517.

Amyloid beta and its naturally occurring N-terminal variants are potent activators of human and mouse formyl peptide receptor 1

Busch L, Al Taleb Z, Tsai YL, Nguyen VTT, Lu Q, Synatschke CV, Endres K, Bufe B.

J Biol Chem. 2022 Dec;298(12):102642. doi: 10.1016/j.jbc.2022.102642. Epub 2022 Oct 27.

Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones

Wu Y, Hang Z, Lei T, Du H.

Neurochem Res. 2022 Dec;47(12):3565-3582. doi: 10.1007/s11064-022-03784-w. Epub 2022 Oct 30.

Geriatric update 2022: Preventing Alzheimer disease and more

Morgan-Gouveia M, Drago K, Harris P, Sheffrin M.

Cleve Clin J Med. 2022 Nov 1;89(11):617-624. doi: 10.3949/ccjm.89a.21094.

Dietary fish oil increases catalase activity in patients with probable Alzheimer's disease

Torres-Mendoza BMG, Ortiz GG, Sánchez-Romero L, Delgado-Lara DLC, García Martínez MT, Mireles-Ramírez MA, Cruz Serrano JA, Pacheco Moisés FP.

Nutr Hosp. 2022 Dec 20;39(6):1364-1368. doi: 10.20960/nh.04153.

Microglial efferocytosis: Diving into the Alzheimer's disease gene pool

Romero-Molina C, Garretti F, Andrews SJ, Marcora E, Goate AM.

Neuron. 2022 Nov 2;110(21):3513-3533. doi: 10.1016/j.neuron.2022.10.015.

Potential of astrocytes in targeting therapy for Alzheimer's disease

Bi W, Lei T, Cai S, Zhang X, Yang Y, Xiao Z, Wang L, Du H.

Int Immunopharmacol. 2022 Dec;113(Pt A):109368. doi: 10.1016/j.intimp.2022.109368. Epub 2022 Oct 29.

Elevated Cortical Tau Positron Emission Tomography Binding in Misery Perfusion: Novel, Puzzling, and Heuristic

Baron JC.

Stroke. 2022 Dec;53(12):e504-e506. doi: 10.1161/STROKEAHA.122.041406. Epub 2022 Nov 7.

Menopause and development of Alzheimer's disease: Roles of neural glucose metabolism and Wnt signaling

Villaseca P, Cisternas P, Inestrosa NC.

Front Endocrinol (Lausanne). 2022 Oct 19;13:1021796. doi: 10.3389/fendo.2022.1021796. eCollection 2022.

N-glycan branching enzymes involved in cancer, Alzheimer's disease and COPD and future perspectives

Taniguchi N, Ohkawa Y, Maeda K, Kanto N, Johnson EL, Harada Y.

Biochem Biophys Res Commun. 2022 Dec 10;633:68-71. doi: 10.1016/j.bbrc.2022.09.027. Epub 2022 Sep 10.

Alzheimer's disease - Where do we go from here?

Bezprozvanny I.

Biochem Biophys Res Commun. 2022 Dec 10;633:72-76. doi: 10.1016/j.bbrc.2022.08.075.

Thirty years of SET/TAF1β/I2PP2A: from the identification of the biological functions to its implications in cancer and Alzheimer's disease

Di Mambro A, Esposito MT.

Biosci Rep. 2022 Nov 30;42(11):BSR20221280. doi: 10.1042/BSR20221280.

ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies

Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC.

Mol Neurodegener. 2022 Nov 8;17(1):72. doi: 10.1186/s13024-022-00574-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias